Investigating Potential Mechanisms of Obesity by Metabolomics
暂无分享,去创建一个
[1] H. Vogel,et al. Differentiating short‐ and long‐term effects of diet in the obese mouse using 1H‐nuclear magnetic resonance metabolomics , 2011, Diabetes, obesity & metabolism.
[2] Peter Kovacs,et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. , 2011, Journal of proteome research.
[3] J. Calviño,et al. Metabolic acidosis-induced insulin resistance and cardiovascular risk. , 2011, Metabolic syndrome and related disorders.
[4] Wolfram Gronwald,et al. Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy , 2011, Metabolomics.
[5] M. Shlipak,et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. , 2011, JAMA.
[6] Hannelore Daniel,et al. Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention. , 2011, Physiological genomics.
[7] V. Mootha,et al. Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.
[8] Jie Tian,et al. Obesity in China: what are the causes? , 2011, Current pharmaceutical design.
[9] Brian J. Bennett,et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.
[10] Jae Ho Park,et al. Metabolomic analysis of livers and serum from high-fat diet induced obese mice. , 2011, Journal of proteome research.
[11] C. Sensen,et al. Metabolomic response to exercise training in lean and diet-induced obese mice. , 2011, Journal of applied physiology.
[12] Ratnesh K Singh,et al. The impact of choline availability on muscle lipid metabolism. , 2011, Food & function.
[13] Liang Zhao,et al. A Metabonomic Comparison of Urinary Changes in Zucker and GK Rats , 2010, Journal of biomedicine & biotechnology.
[14] J. H. Lee,et al. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). , 2010, Journal of proteome research.
[15] Terry K. Smith,et al. The Kennedy pathway—De novo synthesis of phosphatidylethanolamine and phosphatidylcholine , 2010, IUBMB life.
[16] Susan C Connor,et al. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. , 2010, Molecular bioSystems.
[17] G. Mingrone,et al. Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype , 2010, International Journal of Obesity.
[18] Kazuki Saito,et al. Integrated omics approaches in plant systems biology. , 2009, Current opinion in chemical biology.
[19] Seung-Ok Yang,et al. 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet , 2009, Analytical and bioanalytical chemistry.
[20] John C Lindon,et al. ¹H NMR-based metabonomics for investigating diabetes. , 2009, Future medicinal chemistry.
[21] Jesús Brezmes,et al. Metabolic phenotyping of genetically modified mice: An NMR metabonomic approach. , 2009, Biochimie.
[22] B. Nugraha,et al. Metabolomics Study With Gas Chromatography–Mass Spectrometry for Predicting Valproic Acid–induced Hepatotoxicity and Discovery of Novel Biomarkers in Rat Urine , 2009, International journal of toxicology.
[23] H. Yoo,et al. Characterization of Plasma Carnitine Level in Obese Adolescent Korean Women , 2009 .
[24] M. Rantalainen,et al. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. , 2009, Journal of proteome research.
[25] Svati H Shah,et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.
[26] S. Eckhardt,et al. Clinical Applications of Metabolomics in Oncology: A Review , 2009, Clinical Cancer Research.
[27] J. Lindon,et al. Systems biology: Metabonomics , 2008, Nature.
[28] Kai Song,et al. Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet. , 2008, Journal of proteome research.
[29] H. Vogel,et al. Metabolomic profiling of dietary‐induced insulin resistance in the high fat–fed C57BL/6J mouse , 2008, Diabetes, obesity & metabolism.
[30] J. Speakman,et al. The contribution of animal models to the study of obesity , 2008, Laboratory animals.
[31] D. Craik,et al. Altered Metabolism of Growth Hormone Receptor Mutant Mice: A Combined NMR Metabonomics and Microarray Study , 2008, PloS one.
[32] J. Lindon,et al. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. , 2008, Annual review of analytical chemistry.
[33] R. Green,et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet , 2008 .
[34] D. Gauguier,et al. Phylometabonomic Patterns of Adaptation to High Fat Diet Feeding in Inbred Mice , 2008, PloS one.
[35] J. Griffin,et al. Applications of metabolomics to understanding obesity in mouse and man. , 2007, Biomarkers in medicine.
[36] Pengxiang She,et al. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. , 2007, American journal of physiology. Endocrinology and metabolism.
[37] S. McCall,et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis , 2007, Hepatology.
[38] M. Watford. Lowered concentrations of branched-chain amino acids result in impaired growth and neurological problems: insights from a branched-chain alpha-keto acid dehydrogenase complex kinase-deficient mouse model. , 2007, Nutrition reviews.
[39] J. Soh,et al. L-Carnitine Reduces Obesity Caused by High-Fat Diet in C57BL/6J Mice , 2007 .
[40] F. Yoshizawa,et al. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. , 2007, American journal of physiology. Endocrinology and metabolism.
[41] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[42] C. Lynch,et al. Leucine in food mediates some of the postprandial rise in plasma leptin concentrations. , 2006, American journal of physiology. Endocrinology and metabolism.
[43] M. McCarthy,et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.
[44] Martin Kussmann,et al. OMICS-driven biomarker discovery in nutrition and health. , 2006, Journal of biotechnology.
[45] Y. Kamei,et al. Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. , 2006, Endocrinology.
[46] John C. Lindon,et al. Metabonomics Techniques and Applications to Pharmaceutical Research & Development , 2006, Pharmaceutical Research.
[47] Ryutaro Hirose,et al. Metabolic profiling of livers and blood from obese Zucker rats. , 2006, Journal of hepatology.
[48] M. Brändle,et al. Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma. , 2006, Swiss medical weekly.
[49] I. Wilson,et al. A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. , 2006, Molecular bioSystems.
[50] T. Schulz,et al. Chemical inhibition of citrate metabolism alters body fat content in mice. , 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[51] R. Teasdale,et al. In Vivo Analysis of Growth Hormone Receptor Signaling Domains and Their Associated Transcripts , 2005, Molecular and Cellular Biology.
[52] C. Hoppel,et al. Carnitine: a nutritional, biosynthetic, and functional perspective. , 2004, Molecular aspects of medicine.
[53] Robert A. Harris,et al. Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. , 2004, The Journal of nutrition.
[54] S. Kagamimori,et al. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects , 2004, Amino Acids.
[55] J. Wong,et al. Long‐term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial , 2004, Alimentary pharmacology & therapeutics.
[56] S. Amini,et al. Effect of enteral glutamine or glycine on whole-body nitrogen kinetics in very-low-birth-weight infants. , 2004, The American journal of clinical nutrition.
[57] J. Pankow,et al. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2003, The American journal of clinical nutrition.
[58] P. Durrington,et al. Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterol. , 2002, QJM : monthly journal of the Association of Physicians.
[59] T. Lakka,et al. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle‐aged men , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[60] J. ArancetaBartrina. [Prevalence of obesity in developed countries: current status and perspectives]. , 2002 .
[61] T. Weinstein,et al. Glomerular hemodynamics in severe obesity. , 2000, American journal of physiology. Renal physiology.
[62] P. J. Randle,et al. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. , 1998, Diabetes/metabolism reviews.
[63] J. Blusztajn,et al. Choline, a Vital Amine , 1998, Science.
[64] J. Hill,et al. Childhood Obesity: Future Directions and Research Priorities , 1998, Pediatrics.
[65] M. Ohrvall,et al. The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up. , 1996, Atherosclerosis.
[66] S. Mitchell,et al. The exogenous origin of trimethylamine in the mouse. , 1992, Metabolism: clinical and experimental.
[67] J. Bosch,et al. Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease. , 1991, Journal of the American Society of Nephrology : JASN.
[68] E. Alexander,et al. Choline, an essential nutrient for humans , 1991, Nutrition.
[69] M. Jeevanandam,et al. Altered plasma free amino acid levels in obese traumatized man. , 1991, Metabolism: clinical and experimental.
[70] N. Sugino. [Evaluation of renal function in chronic renal disease with special reference to creatinine]. , 1990, Nihon Jinzo Gakkai shi.
[71] A. Golay,et al. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. , 1986, The Journal of clinical endocrinology and metabolism.
[72] G. Marchesini,et al. Insulin-dependent metabolism of branched-chain amino acids in obesity. , 1984, Metabolism: clinical and experimental.
[73] D. Simpson. Citrate excretion: a window on renal metabolism. , 1983, The American journal of physiology.
[74] R. Sherwin. Effect of starvation on the turnover and metabolic response to leucine. , 1978, The Journal of clinical investigation.
[75] P. Felig,et al. Splanchnic glucose and amino acid metabolism in obesity. , 1974, The Journal of clinical investigation.
[76] R. Kreisberg. Glucose-lactate inter-relations in man. , 1972, The New England journal of medicine.
[77] A. Drash,et al. Hormone and amino acid levels in altered nutritional states. , 1970, The Journal of laboratory and clinical medicine.
[78] P. Felig,et al. Plasma amino acid levels and insulin secretion in obesity. , 1969, The New England journal of medicine.
[79] C. Swartz,et al. Creatinine clearance in renal disease. A reappraisal , 1969, British medical journal.
[80] D. Devilliers,et al. Citrate metabolism in diabetes. I. Plasma citrate in alloxan-diabetic rats and in clinical diabetes. , 1966, Metabolism: clinical and experimental.
[81] F. Konishi. THE RELATIONSHIP OF URINARY 17-HYDROXYCORTICOSTEROIDS TO CREATININE IN OBESITY. , 1964, Metabolism: clinical and experimental.
[82] S. Natelson,et al. Dynamic control of calcium, phosphate, citrate, and glucose levels in blood serum. Effect of ACTH, adrenaline, noradrenaline, hydrocortisone, parathormone, insulin, and glucagon. , 1963, Clinical chemistry.
[83] J. Walker. Metabolic control of creatine biosynthesis. II. Restoration of transamidinase activity following creatine repression. , 1961, The Journal of biological chemistry.
[84] H. Popper,et al. Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary diseases. , 1951, The Journal of clinical investigation.
[85] Y. Cha. Effects of L-carnitine on obesity, diabetes, and as an ergogenic aid. , 2008, Asia Pacific journal of clinical nutrition.
[86] E. Pasquali,et al. Insulin resistance and low urinary citrate excretion in calcium stone formers. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[87] P. A. Tataranni,et al. Microarray gene expression profiling in obesity and insulin resistance. , 2004, Nutrition.
[88] R. Green,et al. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. , 2004, Journal of hepatology.
[89] R. Curi,et al. Glutamine and glutamate as vital metabolites. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[90] J. Aranceta Bartrina. [Prevalence of obesity in developed countries: current status and perspectives]. , 2002, Nutricion hospitalaria.
[91] J. Culebras,et al. [Evaluation of Hospital Nutrition III. Delay, subjects and citation]. , 2002, Nutricion hospitalaria.
[92] M. Holeček,et al. The BCAA-BCKA cycle: its relation to alanine and glutamine synthesis and protein balance. , 2001, Nutrition.
[93] Y. Nakaya,et al. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. , 2000, The American journal of clinical nutrition.
[94] H. Satoh. Cardioprotective actions of taurine against intracellular and extracellular calcium-induced effects. , 1994, Advances in experimental medicine and biology.
[95] P. Jansson,et al. Lactate release from the subcutaneous tissue in lean and obese men. , 1994, The Journal of clinical investigation.
[96] G. Walldius,et al. Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. , 1989, International journal of obesity.
[97] A. Kallner,et al. Amino acid pattern in plasma before and after jejuno-ileal shunt operation for obesity. , 1975, Scandinavian journal of gastroenterology.
[98] R. Pitts,et al. The relation between plasma concentrations of glutamine and glycine and utilization of their nitrogens as sources of urinary ammonia. , 1966, The Journal of clinical investigation.
[99] I. Penttila,et al. Effect of insulin acid tolbutamide on blood citric acid in rabbits. , 1959, Scandinavian journal of clinical and laboratory investigation.
[100] I. Penttilä,et al. Effect of Insulin and Tolbutamide on Blood Citric Acid in Rabbits , 1959 .